Nika Pharmaceuticals, Inc
NIKA
Revenue
156.00
▲156.00∞%
15 Months ChangeAssets
390.32k
▲348.85k▲841.15%
3 Months ChangeLiabilities
636.93k
▲370.98k▲139.49%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001826466-24-000131
2024-10-01
Form 8-K
ID: 0001826466-24-000128
2024-09-18
Form 10-Q
ID: 0001826466-24-000120
2024-08-27
Form 8-K
ID: 0001826466-24-000096
2024-05-28
Form 10-Q
ID: 0001826466-24-000068
2024-05-10
Form 8-K
ID: 0001826466-24-000056
2024-04-15
Form 8-K
ID: 0001826466-24-000050
2024-03-05
Form 8-K
ID: 0001826466-24-000020
2024-02-16
Form 8-K
ID: 0001826466-24-000005
2023-10-31
Form 10-Q
ID: 0001826466-23-000038